Intraoperative Dexamethasone and Its Effect on Hyperglycemia
Sponsor
Ascension Genesys Hospital (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03646916
Collaborator
(none)
0
1
2
3.5
0
Study Details
Study Description
Brief Summary
To study the effect of intra-operative dexamethasone on the management of post-operative blood sugar in diabetic patients.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Study Design
Study Type:
Interventional
Actual Enrollment
:
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Effect of Pre-Operative Dexamethasone Dose on the Post-Operative Management of Blood Sugar in Diabetic Patients
Actual Study Start Date
:
Sep 15, 2020
Actual Primary Completion Date
:
Dec 31, 2020
Actual Study Completion Date
:
Dec 31, 2020
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: Dexamethasone
|
Drug: Dexamethasone
Gluco-corticosteroid
Other: No dexamethasone
Nothing
|
No Intervention: Non-treatment
|
Outcome Measures
Primary Outcome Measures
- Post-operative blood sugar [24 hour Post surgery]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
documented history of Type I or Type II Diabetes Mellitus
-
scheduled for surgery that requires patients to be admitted for at least 24 hours post-surgery
Exclusion Criteria:
-
Patients on steroid therapy
-
Pregnant women
-
Patients at low risk for nausea/vomiting
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Genesys Regional Medical Center | Grand Blanc | Michigan | United States | 48439 |
Sponsors and Collaborators
- Ascension Genesys Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Tarik Wasfie, MD,
Principal Investigator,
Ascension Genesys Hospital
ClinicalTrials.gov Identifier:
NCT03646916
Other Study ID Numbers:
- GRMC160010
First Posted:
Aug 24, 2018
Last Update Posted:
Jan 22, 2021
Last Verified:
Jan 1, 2021
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: